BioSpace News Archive

Yiviva, a clinical-stage, platform biotechnology company developing systems biology medicines to treat aging-related diseases, signed a memorandum of understanding with AstraZeneca China to establish a research and development collaboration at AstraZeneca’s Innovation Campus in Chengdu, China.

Genesis MedTech, a leading medical device company, today announced the completion of enrollment in its United States Early Feasibility Study (EFS) using its dedicated transcatheter aortic valve replacement (TAVR) system, J-Valve™ Transfemoral (TF) System.

ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced that findings from Patient-Reported Outcomes (PROs) of participants in the phase 2/3 QUILT 3.032 study of N-803 plus BCG in BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) were published by the peer-reviewed journal Urology Practice.

DirectMed Imaging announces Technical Prospects, the company it acquired in August of 2023, will now fully join forces under the DirectMed Imaging name.

CytoTronics, Inc. revealed its new Pixel ™ system at the 2024 Society for Laboratory Automation and Screening ( SLAS ) international conference and exhibition in Boston, MA.

The American Cancer Society and Pfizer Inc. announced the launch of “Change the Odds™: Uniting to Improve Cancer Outcomes,” a three-year initiative to bridge the gap in cancer care disparities.

GenScript Biotech Corporation, the world’s leading provider of life-science research tools and services, proudly announces the initiation of the GenScript Life Science Research Grant Project.

PANTHERx® Rare is pleased to announce it was selected by Chiesi Global Rare Diseases, a business unit of the Chiesi Group, for the distribution of Filsuvez® topical gel, the first approved treatment for wounds associated with both dystrophic and junctional epidermolysis bullosa (EB) in adult and pediatric patients 6 months of age and older.

The Company intends to delist its common shares from Cboe Canada and is working to ensure that trading of its common shares on the CSE will commence immediately following such delisting, with an effective date to be disclosed in due course.

Bayer AG (BAYRY), a leading global pharmaceutical and biotechnology company, and TetraScience, the Scientific Data and AI Cloud company, today announced an agreement aimed at maximizing the value of scientific data and driving innovation.